Delivery Order SPE2DB20D7066-SPE2DB25FC4MG
- Not listed
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Xeomin 100 unit vials, with a ceiling value of $1,676.22 and a firm fixed price structure. The order is expected to be completed by November 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,349.60 for 200-unit vials of Xeomin on August 26, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeomin 200 Unit Vials with a ceiling value of $2,793.70 and an ultimate completion date of October 2, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a $1,396.85 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Xeomin 100 unit vials, with an ultimate completion date of August 7, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 100-unit vials of Xeomin on October 23, 2025, with a ceiling value of $5,888.20 and completion date of November 14, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child award, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $33,524.40 delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with an ultimate completion date of November 24, 2025. This competitive award, issued on October 31, 2025, utilizes firm fixed pricing and does not include a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $2,793.70 and an ultimate completion date of September 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit vials. This competitively awarded, firm fixed price contract was issued on August 27, 2025, with an ultimate completion date of September 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a non-set-aside procurement, this delivery order was competed among qualified...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4MGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xeomin 200 unit vials valued at $23.5K with a completion date of September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp fulfills this order as part of its extensive portfolio of drug and medical supply deliveries to military and veteran healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9M and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Xeomin, a botulinum toxin treatment, represents one of the specialized pharmaceutical commodities available through this expansive contract vehicle that covers brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 8/25/25 |